Extra oxygen breathing for people with a new spinal cord injury
Tests breathing extra oxygen in ventilated adults with a traumatic spinal cord injury.
Key facts
- Who runs it
- University of Florida
- Where
- Gainesville, United StatesSee the site
- Trial code
- Registry title
- Treating Spinal Cord Injury With Early Normobaric Hyperoxia
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 12 people, planned
- Started
- 31 Oct 2026
- Expected to end
- 30 Sept 2028
- Type of study
- Interventional
- Treatments tested
- Normobaric Hyperoxia
- Record updated
- 9 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a recent injury to the spinal cord in the neck or upper back who need a breathing machine. They will get extra oxygen at normal air pressure.
- Age
- 18 to 85 years
- Sex
- All sexes
- Disease stage
- Blunt or penetrating injury to the spinal cord in the neck (cervical) and/or upper back (thoracic), with the sac around the cord intact. Injury grade AIS A, B or C. People must be awake, able to follow commands, and need a breathing machine. Treatment must be able to start within 24 hours of injury.
- Biomarker or test result
- Blood oxygen level (PaO2) above 80 mmHg before joining.
Main reasons for not taking part
- Any brain injury seen on CT or MRI scans
- Injury grade AIS D or E on arrival at hospital
- Low oxygen needing more than 40% FiO2 to keep PaO2 above 80 mmHg
- Injuries or bleeding problems that rule out a lumbar drain, such as platelets below 100,000/μL or INR above 1.5
- Pregnancy, or existing nerve or lung conditions that would affect the trial's assessments
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Provision of signed and dated ICF by the subject or LAR
- Stated willingness to comply with all study procedures for the duration of the study
- Male or female subjects, aged ≥18 and ≤ 85 years
- Admitted with a diagnosis of blunt or penetrating traumatic cervical and/or thoracic SCI (maintaining dural sac integrity)
- Awake and able to interact and follow commands
- American Spinal Injury Association (ASIA) Impairment Scale (AIS) grades A, B or C
- Need for mechanical ventilation (MV), as determined by the treating physician
- Baseline PaO2 >80 mmHg before enrollment
- Capacity to initiate the study intervention within 24 hours of injury
Who cannot take part
- Concurrent injuries contraindicating lumbar drain placement, including, but not limited to: signs of infection at insertion site, elevated intracranial pressure, supratentorial mass lesion with mass effect, posterior fossa mass or uncorrected coagulopathy (thrombocytopenia <100,000/μL or International Normalized Ratio >1.5)
- Participation in a concurrent investigational/interventional study (observational studies allowed)
- Evidence of traumatic brain injury by neuroimaging (either CT or MRI) including, but not limited to, traumatic subarachnoid hemorrhage, subdural hematoma, epidural hematoma, intracranial hemorrhage, parenchymal contusions, and blunt cerebrovascular injury grades II-V
- Pre-existing neurologic conditions that would confound neurologic assessment or would make difficult to accurately assess neurologic and/or functional outcomes
- Pre-existing respiratory or pulmonary conditions that would impact ventilation mechanics or confound the assessment of respiratory recovery
- Patient has any other clinically significant medical condition as determined by the investigator, that may unfavorably alter the risk-benefit of study participation, adversely affect study compliance, or confound interpretation of study results
- AIS grades D or E at time of arrival to hospital
- Persistent hypoxia requiring >40% FiO2 to maintain PaO2 >80 mmHg
- Known to be pregnant, or with a positive pregnancy test
- Vulnerable populations such as prisoners and inmates (abiding GCP per the study IRB)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in United States
- University of FloridaGainesville, United StatesContact: Andrew KlineTaking people
About the trial
What the trial wants to find out
SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.
The group in the trial
- InterventionTreatment being tested
Normobaric hyperoxia
Treatment: Normobaric Hyperoxia
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Treating Spinal Cord Injury With Early Normobaric Hyperoxia - A Phase IIa Feasibility Trial
- Plain-language title
- Extra oxygen breathing for people with a new spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07465302, who can take part
- Record updated
- 9 November 2026